Repurposing Butenafine as An Oral Nanomedicine for Visceral Leishmaniasis
Leishmaniasis is a neglected tropical disease affecting more than 12 million people worldwide, which in its visceral clinical form (VL) is characterised by the accumulation of parasites in the liver and spleen, and can lead to death if not treated. Available treatments are not well tolerated due to...
Saved in:
Main Authors: | Adriana Bezerra-Souza (Author), Raquel Fernandez-Garcia (Author), Gabriela F. Rodrigues (Author), Francisco Bolas-Fernandez (Author), Marcia Dalastra Laurenti (Author), Luiz Felipe Passero (Author), Aikaterini Lalatsa (Author), Dolores R. Serrano (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2019-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanostructured Lipid Carriers as Robust Systems for Lupeol Delivery in the Treatment of Experimental Visceral Leishmaniasis
by: Jéssica Adriana Jesus, et al.
Published: (2023) -
Microfluidic Manufacture of Lipid-Based Nanomedicines
by: Karim Osouli-Bostanabad, et al.
Published: (2022) -
Preclinical Assessment of Ursolic Acid Loaded into Nanostructured Lipid Carriers in Experimental Visceral Leishmaniasis
by: Jéssica Adriana Jesus, et al.
Published: (2021) -
Análise TG-ROC de testes de imunofluorescência no diagnóstico de leishmaniose visceral canina Análisis TG-ROC de pruebas de inmunofluorescencia en el diagnóstico de leishmaniasis visceral canina TG-ROC analysis of immunofluorescence assays in canine visceral leishmaniasis diagnosis
by: Rita Maria da Silva, et al.
Published: (2009) -
Therapeutic Activity of a Topical Formulation Containing 8-Hydroxyquinoline for Cutaneous Leishmaniasis
by: Sarah Kymberly Santos de Lima, et al.
Published: (2023)